Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response

Akinori Kimura1

  • 1Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Japan. akitis@mri.tmd.ac.jp

Journal of Human Genetics
|January 16, 2010
PubMed

Insights

Genetic mutations in cardiomyopathy can cause different clinical types, affecting cardiac muscle function. Understanding these genetic links offers new therapeutic strategies for hereditary heart muscle diseases.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathy stems from cardiac muscle functional abnormalities, with intrinsic factors causing primary or idiopathic forms.
  • Primary cardiomyopathies include hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM).
  • Hereditary primary cardiomyopathy research has identified disease genes through linkage studies and candidate gene approaches.

Purpose of the Study:

  • To explore the genetic etiology and functional alterations in hereditary primary cardiomyopathies.
  • To investigate the relationship between specific gene mutations and different clinical cardiomyopathy types.
  • To identify potential therapeutic targets based on elucidated genetic and functional mechanisms.

Main Methods:

  • Linkage studies and candidate gene approaches to identify disease genes.
  • Functional analyses of disease-related mutations.
  • Investigating mutations in sarcomere, Z-disc, and I-region components.

Main Results:

  • Mutations in the same gene can manifest as different cardiomyopathy types (HCM, DCM).
  • Sarcomere mutations are linked to altered Ca(2+) sensitivity (increased in HCM, decreased in DCM).
  • Z-disc and I-region mutations are associated with altered sarcomere stiffness and stress response, respectively.

Conclusions:

  • Elucidating genetic causes and functional impacts of mutations provides insights into cardiomyopathy pathogenesis.
  • Understanding these mechanisms opens avenues for novel therapeutic strategies for hereditary cardiomyopathies.
  • Targeting specific functional alterations, like Ca(2+) sensitivity in DCM, shows promise in preclinical models.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...